Annals of the Rheumatic Diseases

Publisher
BMJ Group
Country
United Kingdom
History
1993–present
Website
http://ard.bmj.com
Impact factor
8.110 (2009)

Some content from Wikipedia, licensed under CC BY-SA

Arthritis & Rheumatism

Updated recommendations for psoriatic arthritis

Psoriatic arthritis (PsA) is an autoimmune inflammatory disease. It has both joint and non-joint symptoms and manifestations, which can vary from person to person. It is commonly associated with psoriasis that affects the ...

Arthritis & Rheumatism

Updated EULAR recommendations for hip and knee osteoarthritis

Osteoarthritis (OA) affects more than 500 million people worldwide. The disease is age-related, and usually starts to affect people in middle age. For elderly people, OA is the most common cause of disability, resulting in ...

Arthritis & Rheumatism

Updated systemic lupus erythematosus management recommendations

Systemic lupus erythematosus (SLE) is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical ...

Arthritis & Rheumatism

Updated antiphospholipid syndrome classification criteria

Antiphospholipid syndrome (APS) is a systemic autoimmune disease associated with persistent antiphospholipid antibodies (aPL). It can cause thrombosis and pregnancy complications as well as non-thrombotic manifestations such ...

page 1 from 15